Welcome to the News & More section. Here you will find general information in the form of press releases, news and the latest graphical material.
Berlin-Chemie has been developing, manufacturing and distributing pharmaceutical products for over 130 years and has been a wholly owned subsidiary of the Menarini Group, the leading Italian pharmaceutical company, since 1992.
For patients, we provide the latest patient information leaflets and training materials as well as the technical information for Berlin-Chemie products available in Germany via our Medical Hub.
Responsibility is a top priority at Berlin-Chemie. We not only make an important contribution to healthcare, but also put our values into practice through various social initiatives.
Discover More about Global Responsibility
From school kits to free meals and medicines, to caring for the environment around the world. In Menarini, being responsible means translating our values into concrete actions that are good for others and good for the planet
Berlin-Chemie – a strong partner. Our many years of experience and the success of joint projects make us the partner of choice.
Discover More about Global Partnering
Menarini has in-depth know-how in many important therapeutic areas, thanks to many years of excellent market introduction, marketing and sales capabilities as well as expertise in regulatory aspects and market access. Collaboration is the key to great success, and at Menarini, partnership is part of the DNA.
Our holistic and professional health management offers doctors individual counselling, training or workshops, events and lectures on many topics, depending on their needs.
Our Medical Hub acts as a central point of contact for doctors and healthcare professionals. Here you will find all the information about our medications, additional service and training opportunities.
Menarini Blog
Follow Us
We employ professionals with a wide variety of career backgrounds and are employers who care about their staff. Together, we stand for innovation and reliability.
Our Job Portal
Find out about our current vacancies at Berlin-Chemie directly on our career portal.
2025 - 09 - 12
Han Steutel is the new Chairman of the Board at Berlin-Chemie
Berlin-Adlershof, September 12, 2025 – Han Steutel took over as Chairman of the Board of Berlin-Chemie AG on September 1, 2025. In this role, which primarily involves representative and coordinating tasks, he brings his many years of international experience to bear.
Han Steutel has been President of the German Association of Research-Based Pharmaceutical Companies (vfa) since 2019 and will continue in this role.
Steutel looks back on a long international career in the pharmaceutical industry: he began his career at AstraZeneca in the Netherlands in 1987 and moved to Bristol-Myers Squibb in 1999. There, he took on responsibility as General Manager of the Dutch subsidiary in 2003 and, five years later, became Managing Director of Bristol-Myers Squibb Germany. He then served as Senior Vice President & General Manager Germany. In addition to his entrepreneurial activities, Han Steutel is a member of the Presidium of the Federation of German Industries (BDI) and the Board of Directors of the American Chamber of Commerce (AmCham).
Han Steutel succeeds Luca Lastrucci, who retired from the Executive Board on August 31, 2025. Berlin-Chemie would like to express its sincere gratitude for his many years of commitment, his strategic foresight, and his lasting contribution to the company, and wishes him all the best for this new chapter in his life.
About Berlin-Chemie
Berlin-Chemie AG is an internationally active, research-based pharmaceutical company founded in 1890 and based in Berlin-Adlershof. Since 1992, the company has been a subsidiary of the Italian Menarini Group and is responsible within the group for the primary care business in Germany and in over 30 countries in Central and Eastern Europe and Central Asia. The group's largest production site is located in Berlin, where high-quality medicines are manufactured for over 90 countries worldwide. Berlin-Chemie generated sales of around €1.48 billion in 2024 and employs around 1,500 people in the Berlin-Brandenburg region.